Table 3.
Reduction of enzymes [tissue] | MT-CYB | CYC1 | UQCRB | UQCRC2 | UQCRQ | UQCC2 | UQCC2 | UQCC3 | TTC19 | LYRM7 | BCS1L |
---|---|---|---|---|---|---|---|---|---|---|---|
Complex III [muscle] | Yes | 3§/3 | n.a. | 1§/1 | 3/3 (22 = n.a.) | 1/1 | 1/1 | 1/1 | Most | 6/9 (3 = n.a.) | Reduced |
Complex III [fibroblasts] | Yes | 2/2 | 1/1 | 2/2 (2 = n.a.) | n.a. | 1/1 | 0/1 | 1/1 | Some | 1/9 (8 = n.a.) | Reduced |
Complex III [liver] | 1/1 (1 = n.a.) | 1/1 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 1/9 (8 = n.a.) | Variable | |
Complex I [muscle] | Yes | 1§/2 (1 = n.a.) | n.a. | 1§/1 | 3/3 (22 = n.a.) | 1/1 | 1/1 | 1/1 | Normal | 1/9 (8 = n.a.) | Variabe |
Complex I [fibroblasts] | n.a. | n.a. | 1/2 (2 = n.a.) | n.a. | 1/1 | 0/1 | 0/1 | Normal | n.a. | Variable | |
Complex I [liver] | 1/1 (1 = n.a.) | 1/1 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Variable | |
Complex I [BN-PAGE] fibroblasts | Muscle | 1/2 | n.a. | 2/2 (2 = n.a.) | n.a. | 1/1 | 0/1 | 1/1 | Normal | 0/1 (8 = n.a.) | Variable |
Complex IV [muscle] | 1§/3 | n.a. | 1§/1 | 2/3 (22 = n.a.) | 1/1 | Reduced | 0/1 | Normal | n.a. | Variable | |
Complex IV [fibroblasts] | 0/1 (1 = n.a.) | 1/1 | 0/2 (2 = n.a.) | n.a. | 1/1 | 0/1 | 0/1 | Normal | n.a. | Variable | |
Complex IV [liver] | 0/1 (1 = n.a.) | 0/1 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | ||
Complex IV [BN-PAGE] fibroblasts | 0/2 | n.a. | 1/2 (2 = n.a.) | n.a. | Normal | n.a. | 0/1 | Normal | 0/1 (8 = n.a.) | Variable | |
Literature | Gasparre et al. [3] Zimmermann et al. [9] Blakely et al. [39] | Gaignard et al. [34], §one patient from Tucker et al. [7], no values provided | Haut et al. [22] | Gaignard et al. [34], Gasparre et al. [3], §one patient from Tucker et al. [7], no values provided | Barel et al. [1] | Tucker et al. [7] | This study | Wanschers et al. [8] | Koch et al. [5], Ardissone et al. | Invernizzi et al. [4] Dallabona et al. [24] Kremer et al. [10] | Moran et al. [23] |